CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 4 Open-market buy Chief Executive Officer bought 58,959 shares at $9.99 ($589,000)
- 4 Open-market buy Chief Development Officer bought 11,111 shares at $9.99 ($110,999)
- 4 Open-market buy See Remarks bought 10,010 shares at $9.99 ($100,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 2,537,110 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- CT ORDER Other Confidential Order
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- 10-K/A Report 10-K/A
- DEFM14A Deal DEFM14A
- UPLOAD Other SEC-generated Letter
- PRER14A Other PRER14A
Page 23 of 31 · 616 filings